Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-04-09 @ 4:20 AM
Study NCT ID:
NCT01065935
Status:
COMPLETED
Last Update Posted:
2018-02-05
First Post:
2010-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Sponsor:
Alnylam Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALN-RSV01-109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None